Trivitron Healthcare Private Limited has entered into a strategic partnership by signing a Memorandum of Association (MoU) with the Centre for Cellular and Molecular Platforms (C-CAMP), an initiative of the Department of Biotechnology, Ministry of Science and Technology and Earth Sciences, Government of India. This partnership is a strategic step for both Trivitron and C-CAMP toward co-development of world-class healthcare technologies completely indigenously under Joint Intellectual Properties (i.e., product and process patents and know-how) aegis. The MoU was signed in the presence of Dr Renu Swarup, secretary, department of biotechnology, Ministry of Science and Technology, Government of India and chairperson, Biotechnology Industry Research Assistance Council (BIRAC); Dr Taslimarif Saiyed, CEO and director, C-CAMP; and Dr GSK Velu, chairman and managing director, Trivitron Healthcare Private Limited.
C-CAMP has developed and tested an indigenous multiplex fluorescent microfluidic-analyzer, covered under two patents: a base-patent for microfluidics flow analyzer, which is filed and granted in several geographies, and a follow-on patent covering multiplex functionality. C-CAMP will demonstrate proof of concept and will participate in the co-development of a biological fluid analyzer for clinical diagnostics. By the MoU, Trivitron, which has a history of developing and installing diagnostic devices, including imaging devices globally, is expected to facilitate the C-CAMP-developed technologies in reaching a wider market segment commercially.
Trivitron will also work along with C-CAMP to co-develop other relevant technologies and devices in the fields of point-of-care testing, microfluidics, and multiplex detection, which are within the domain of expertise and of strategic interest to Trivitron and C-CAMP.
Dr GSK Velu
Chairman and Managing Director,
Trivitron Healthcare Private Limited
“We are delighted to be partnering with C-CAMP. They are today among India’s most exciting and unique life sciences innovation hubs that brings together academia, industry, and the startup ecosystem on one platform. India is today witnessing massive development in the healthcare space, opening avenues for new advancements and innovations. As a medical technology company providing affordable healthcare solutions, Trivitron constantly pursues technological innovations to offer superior, and yet cost-effective, clinical benefits. The alliance with C-CAMP is in line with this endeavor and we are confident that C-CAMP’s culture of innovation and excellence will enable us to provide technologically more advanced devices for enhanced diagnosis and treatments.”